Новые правила оплаты регистрации лекарственных средств и медицинских изделий в Узбекистане
December 03, 2024Inpharmatis and “ACADEMPHARM” Discussed in Minsk Cooperation Opportunities
The Head of the Development Department of Inpharmatis Andrey Berman met in Minsk with representatives of the State Enterprise "ACADEMPHARM" to discuss the prospects for cooperation in the area of drug registration in the EAEU and the European Union.
During the meeting at the International Medical Forum "Health" in Minsk, the parties discussed the prospects for cooperation in pharmacovigilance, registration of medicines, and dietary supplements. Andrey Berman spoke about the experience of Inpharmatis and successfully implemented projects in the markets of Europe, the EAEU, the CIS in the interests of the largest pharmaceutical companies. The parties agreed to exchange detailed information to explore opportunities for cooperation.
"ACADEMPHARM" is a state-owned pharmaceutical enterprise of the Republic of Belarus, which started with the release of 6 drugs, and in 2019 already produced 40 items. As Andrey Berman noted, Inpharmatis has more than 15 years of successful experience in the EAEU, CIS, and Europe and offers a full range of services in regulatory matters, pharmacovigilance, GMP and GDP audit, PIL Readability User Testing, as well as electronic solutions for the pharmaceutical industry and regulatory authorities.
Andrey Berman, Head of the Development Department of Inpharmatis, takes part in the largest International Medical Forum in the Republic of Belarus. The event has been held annually in Minsk for over 25 years, its main goal is the development of the pharmaceutical industry of the Republic of Belarus and the strengthening of international cooperation.
New Payment Rules for Medicines and Medical Device Registration in Uzbekistan
December 03, 2024Inpharmatis открыла юридическое лицо в Узбекистане
November 28, 2024Inpharmatis Opens an LLC Legal Entity in Uzbekistan
November 28, 2024Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
October 16, 2024Dr. Polina Dombure to Speak at TOPRA Webinar "Navigating Regulatory Changes in Moldova and Ukraine"
October 16, 2024Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
September 13, 2024Dr. Polina Dombure to Speak at TOPRA Webinar on “Overcoming Regulatory Challenges in Azerbaijan and Georgia”
September 13, 2024